Manufacture of cell therapy materials, namely, autologous and allogenic cell-based therapy pharmaceuticals to the order and specification of others; manufacture of viral and non-viral vectors to the order and specification of others; manufacture of cellular vaccines, CAR-T therapy materials, namely, chimeric antigen receptor T cell-based pharmaceuticals, TCR-T therapy materials, namely, T cell receptor T cell-based pharmaceuticals, and CAR-NK therapy materials, namely, chimeric antigen recept...